Crohn's disease
Overview
A type of chronic inflammatory bowel disease that causes inflammation throughout the gastrointestinal (GI) tract. In individuals with Crohn’s disease, inflammation occurs as autoantibodies attack cells in the intestinal region of the GI tract. Notably, the inflammation may appear and reappear throughout time, with flare-ups sometimes occurring in response to dietary choices or medication disruptions/changes.
Inflammation can occur anywhere along the GI tract in continuous or segmented regions, though the specific location of this inflammation is unique to each person. Consequently, Crohn’s disease is typically categorized according to which part or parts of the gut are most affected.
Common Symptoms
Severe diarrhea or constipation, fever, fatigue, weight loss, malnutrition, abdominal pain, rectal bleeding/blood in your stool, mouth sores, inflammation of the skin, eyes, joints, liver, or bile ducts, kidney stones, anemia, and delayed physical or sexual development.
Coexisting Diseases and Conditions
There is a debate as to the existence of a connection between Crohn’s disease and celiac disease, but all conclude that Crohn’s disease is more common in those with celiac disease than in the general population. Overlapping symptoms between the two conditions include abdominal pain, diarrhea, anemia, and short stature.
Patients with Crohn’s disease and ulcerative colitis have a similarly increased risk of depression and anxiety after surgery or hospitalization. Additionally, these patients have to worry about chronic diseases, extraintestinal manifestations, and more “piggybacking” on their illness.
Recent research shows that inflammatory bowel disease (Crohn’s disease and ulcerative colitis) may lead to the development of psoriasis and psoriatic arthritis.
Risk Factors and Prevalence
The cause of Crohn’s disease is still unknown, but genetic links are suspected due to evidence that has found multiple members of the same family affected.
Diet, nonsteroidal anti-inflammatory medications (like ibuprofen or naproxen sodium), cigarette smoking, and stress may aggravate Crohn’s disease, but do not cause the disease. Recent research suggests that hereditary, genetic, immunological, and environmental factors contribute to Crohn’s disease development.
Caucasians of Ashkenazi Jewish descent and people of African descent in North American and the United Kingdom are among the most at-risk individuals to develop Crohn’s disease.
Recent Research
- A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn’s Disease (UNITI Jr) (2026)
- Antioxidants, minerals and vitamins in relation to Crohn’s disease and ulcerative colitis: A Mendelian randomization study (2023)
- Modulating the Microbiome for Crohn’s Disease Treatment (2023)
- Autophagy in Crohn’s Disease: Converging on Dysfunctional Innate Immunity (2023)
- Food Processing and Risk of Crohn’s Disease and Ulcerative Colitis: A European Prospective Cohort Study (2023)
- Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn’s disease (2023)
Sources
- Sources
Ballester Ferré, M. P., Boscá-Watts, M. M., & Mínguez Pérez, M. (2018). Crohn’s disease. Enfermedad de Crohn. Medicina clinica, 151(1), 26–33. https://doi.org/10.1016/j.medcli.2017.10.036
Petagna, L., Antonelli, A., Ganini, C., Bellato, V., Campanelli, M., Divizia, A., Efrati, C., Franceschilli, M., Guida, A. M., Ingallinella, S., Montagnese, F., Sensi, B., Siragusa, L., & Sica, G. S. (2020). Pathophysiology of Crohn’s disease inflammation and recurrence. Biology direct, 15(1), 23. https://doi.org/10.1186/s13062-020-00280-5
Caparrós, E., Wiest, R., Scharl, M., Rogler, G., Gutiérrez Casbas, A., Yilmaz, B., Wawrzyniak, M., & Francés, R. (2021). Dysbiotic microbiota interactions in Crohn’s disease. Gut microbes, 13(1), 1949096. https://doi.org/10.1080/19490976.2021.1949096
Shen, B., Remzi, F. H., Hammel, J. P., Lashner, B. A., Bevins, C. L., Lavery, I. C., Wehkamp, J., & Fazio, V. W. (2009). Family history of Crohn’s disease is associated with an increased risk for Crohn’s disease of the pouch. Inflammatory bowel diseases, 15(2), 163–170. https://doi.org/10.1002/ibd.20646
Abegunde, A. T., Muhammad, B. H., Bhatti, O., & Ali, T. (2016). Environmental risk factors for inflammatory bowel diseases: Evidence based literature review. World journal of gastroenterology, 22(27), 6296–6317. https://doi.org/10.3748/wjg.v22.i27.6296
Brant, S. R., Fu, Y., Fields, C. T., Baltazar, R., Ravenhill, G., Pickles, M. R., Rohal, P. M., Mann, J., Kirschner, B. S., Jabs, E. W., Bayless, T. M., Hanauer, S. B., & Cho, J. H. (1998). American families with Crohn’s disease have strong evidence for linkage to chromosome 16 but not chromosome 12. Gastroenterology, 115(5), 1056–1061. https://doi.org/10.1016/s0016-5085(98)70073-3
Shehada, M., & McMahon, L. E. (2024). Recurrent Crohn’s disease. Seminars in pediatric surgery, 33(2), 151403. https://doi.org/10.1016/j.sempedsurg.2024.151403
Feakins R. M. (2014). Ulcerative colitis or Crohn’s disease? Pitfalls and problems. Histopathology, 64(3), 317–335. https://doi.org/10.1111/his.12263
Yu, Y. R., & Rodriguez, J. R. (2017). Clinical presentation of Crohn’s, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes. Seminars in pediatric surgery, 26(6), 349–355. https://doi.org/10.1053/j.sempedsurg.2017.10.003
Ananthakrishnan, A. N., Gainer, V. S., Cai, T., Perez, R. G., Cheng, S.-C., Savova, G., Chen, P., Szolovits, P., Xia, Z., De Jager, P. L., Shaw, S., Churchill, S., Karlson, E. W., Kohane, I., Perlis, R. H., Plenge, R. M., Murphy, S. N., & Liao, K. P. (2013). Similar risk of Depression and Anxiety following surgery or hospitalization for Crohn’s disease and Ulcerative colitis. The American Journal of Gastroenterology, 108(4), 594–601. https://doi.org/10.1038/ajg.2012.471
Ghersin, I., Khateeb, N., Katz, L. H., Daher, S., Shamir, R., & Assa, A. (2020). Comorbidities in adolescents with inflammatory bowel disease: Findings from a population-based cohort study. Pediatric Research, 87(7), 1256–1262. https://doi.org/10.1038/s41390-019-0702-3
Parakala, M. (n.d.). Fatigue, sleep, and IBD – A patient perspective. ImproveCareNow. Retrieved from https://www.improvecarenow.org/fatigue_sleep_and_ibd_a_patient_perspective